Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules
Al-Alwan, Monther, Olabi, Safiah, Ghebeh, Hazem, Barhoush, Eman, Tulbah, Asma, Al-Tweigeri, Taher, Ajarim, Dahish, Adra, Chaker
Published in PloS one (04.11.2011)
Published in PloS one (04.11.2011)
Get full text
Journal Article
Development of Epirubicin-Loaded Biocompatible Polymer PLA-PEG-PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment
Massadeh, Salam, Almohammed, Iman, Barhoush, Eman, Omer, Mustafa, Aldhawi, Nouf, Almalik, Abdulaziz, Alaamery, Manal
Published in Polymers (09.04.2021)
Published in Polymers (09.04.2021)
Get full text
Journal Article
FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy
Ghebeh, Hazem, Barhoush, Eman, Tulbah, Asma, Elkum, Naser, Al-Tweigeri, Taher, Dermime, Said
Published in BMC cancer (23.02.2008)
Published in BMC cancer (23.02.2008)
Get full text
Journal Article
Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule
Ghebeh, Hazem, Lehe, Cynthia, Barhoush, Eman, Al-Romaih, Khaldoon, Tulbah, Asma, Al-Alwan, Monther, Hendrayani, Siti-Faujiah, Manogaran, Pulicat, Alaiya, Ayodele, Al-Tweigeri, Taher, Aboussekhra, Abdelilah, Dermime, Said
Published in Breast cancer research : BCR (01.01.2010)
Published in Breast cancer research : BCR (01.01.2010)
Get full text
Journal Article
Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
Ghebeh, Hazem, Sleiman, Ghida Majed, Manogaran, Pulicat S, Al-Mazrou, Amer, Barhoush, Eman, Al-Mohanna, Falah H, Tulbah, Asma, Al-Faqeeh, Khalid, Adra, Chaker N
Published in BMC cancer (14.06.2013)
Published in BMC cancer (14.06.2013)
Get full text
Journal Article
Expression Proteomics As Surrogate Biomarkers For Early Treatment Response In Chronic Myeloid Leukemia (CML) Patients
Alaiya, Ayodele, Chaudhri, Naeem, Owaidah, Tarek, Fox, Jonathan, Shinwari, Zakia, Barhoush, Eman, Alsharif, Fahad, Mohamed, Said Y, Rasheed, Walid, Alfraih, Feras, Aljurf, Mahmoud
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Proteomic analysis of soft tissue tumor implants treated with a novel polybisphosphonate
Alaiya, Ayodele, Fox, Jonathan, Bobis, Steve, Matic, Goran, Shinwari, Zakia, Barhoush, Eman, Márquez, Marcela, Nilsson, Sten, Holmberg, Anders R
Published in Cancer genomics & proteomics (01.01.2014)
Get full text
Published in Cancer genomics & proteomics (01.01.2014)
Journal Article
Profiling of normal and malignant breast tissue show CD44high/CD24lowphenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
Ghebeh, Hazem, Sleiman, Ghida Majed, Manogaran, Pulicat S, Al-Mazrou, Amer, Barhoush, Eman, Al-Mohanna, Falah H, Tulbah, Asma, Al-Faqeeh, Khalid, Adra, Chaker N
Published in BMC cancer (14.06.2013)
Published in BMC cancer (14.06.2013)
Get full text
Journal Article
FOXP3.sup.+ .sup.T.sub.regs and B7-H1.sup.+.sup./PD-1.sup.+ .sup.T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy
Ghebeh, Hazem, Barhoush, Eman, Tulbah, Asma, Elkum, Naser, Al-Tweigeri, Taher, Dermime, Said
Published in BMC cancer (23.02.2008)
Published in BMC cancer (23.02.2008)
Get full text
Journal Article
FOXP3 super(+ )T sub(regs )and B7-H1 super(+)/PD-1 super(+ )T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy
Ghebeh, Hazem, Barhoush, Eman, Tulbah, Asma, Elkum, Naser, Al-Tweigeri, Taher, Dermime, Said
Published in BMC cancer (01.01.2008)
Published in BMC cancer (01.01.2008)
Get full text
Journal Article